
Reid Hoffman leaves Microsoft board to focus on AI drug startup Manus
Reid Hoffman is stepping down from Microsoft's board after a decade, to concentrate on his AI-driven drug discovery startup, Manus. Hoffman joined Microsoft’s board following its acquisition of LinkedIn in 2016 and was involved in key AI investments,...
